期刊文献+

新诊断2型糖尿病并非酒精性脂肪肝的相关因素分析

Related Factors for Newly Diagnosed Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease
下载PDF
导出
摘要 目的:探讨新诊断2型糖尿病患者(T_2DM)并非酒精性脂肪肝(NAFLD)的相关因素。方法:比较新诊断T_2DM并NAFLD(DFL)和未合并NAFLD(NDFL)患者的各种生化指标,Logistic回归方法分析T_2DM并NAFLD的相关因素。结果:与NDFL组相比较,DFL组的体重指数(BMI)、腰围、谷丙转氨酶(ALT)、谷草转氨酶(AST)、Ln(C肽曲线下面积)[Ln(CPAUC)]、甘油三脂(TG)和尿酸明显增高(P<0.05);DFL组腰围≥85 cm,BMI≥25 kg/m^2,血脂异常、尿酸≥350μmol/L,代谢综合征和Ln(CPAUC)≥12的患者比例明显高于NDFL组(P<0.05);Logistic回归分析显示:腰围≥85 cm和Ln(CPAUC)≥12是新诊断T_2DM并NAFLD的独立危险因素(P<0.05)。结论:新诊断T_2DM患者的NAFLD与各种代谢异常密切相关,胰岛素抵抗是其主要的危险因素,反映中心性肥胖的腰围可作为其一个重要的预测因素。 Objective: To investigate the related factors for newly diagnosed type 2 diabetes mellitus (T2DM) patients with nonalcoholic fatty liver disease (NAFLD). Method: Biochemical indices between newly diagnosed T2DM patients with and without NAFLD (DFL and NDFL) were compared. The related factors for newly diagnosed T2DM patients with NAFLD were analyzed by Logistic analysis. Results: Compared with NDFL group,the BMI,waist circumference,ALT,AST,Ln (CPAUC), triglycerid and uric acid in DFL group were significantly higher (P〈0.05). The patients with waist circumference ≥85 cm,BMI ≥25 kg/m2,dyslipidemia,uric acid ≥350 μmol/L,metabolic syndrome and Ln (CPAUC)≥ 12 in DFL group were significantly more than those in NDFL group (P〈O.05). Waist circumference ≥ 85 cm and Ln (CPAUC) were independent risk factors for newly diagnosed T2DM patients with NAFLD by Logistic analysis(P〈0.05). Conclusion: NAFLD in newly diagnosed T2DM patients has close relationship with all kinds of metabolic abnormality. Insulin resistance is the major risk factor for newly diagnosed T2DM patients with NAFLD. Waist circumference, as an indirect factor for central obesity, may be an important predictive factor for NAFLD in newly diagnosed T2DM patients.
出处 《岭南急诊医学杂志》 2012年第1期15-17,38,共4页 Lingnan Journal of Emergency Medicine
关键词 2型糖尿病 非酒精性脂肪肝 胰岛素抵抗 type 2 diabetes mellitus nonalcoholic fatty liver disease insulin resistance
  • 相关文献

参考文献8

二级参考文献21

  • 1《中国糖尿病防治指南》(试行本)(节选)[J].中国慢性病预防与控制,2004,12(6):283-285. 被引量:304
  • 2张安玉.针对超重和肥胖的2型糖尿病病人和糖尿病前期病人的新指南[J].中国慢性病预防与控制,2005,13(4). 被引量:3
  • 3Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD single topic conference[J].Hepatology,2003,37 (5):1202-1209.
  • 4Thamer C,Machann J,Haap M,et al,Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects[J].Diabetes Care,2004,27(11):2726-2729.
  • 5Diehl AM,Li ZP,Lin HZ,et al.Cytokines and the pathogenesis of non-alcoholic steatohepatitis[J].Gut,2005,54 (2):303-306.
  • 6Kelley DE,McKolanis TM,Hegazi RA,et al.Fatty liver in type 2diabetes mellitus:relation to regional adiposity,fatty acids,and insulin resistance[J].Am J Physiol Endocrinol Metab,2003,285(4):906-916.
  • 7Berg AH,Scherer PE.Adipose tssue,inflammation,and cardiovascular disease[J].Circ Res,2005,96 (9):939 -949.
  • 8Hutley L,Prins JB.Fat as an endocrine organ:relationship to the metabolic syndrome[J].Am J Med Sci,2005,330(6):280-289.
  • 9Sathyaprakash R,Henry RR.Preventing diabetes by treating aspects of the metabolic syndrome[J].Curr Diab Rep,2002,2(5):416-422.
  • 10Antic V,Dulloo A,Montani JP.Multiple mechanisms involved in obesity-induced hypertension[J].Heart Lung Circ,2003,12(2):84-93.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部